Analytics MLabs teams helped an F100 biopharma firm innovate top-end analytics solutions to boost process oversight and efficiency of the finance function
Problem
Organizations today are looking for highly-calibrated analytics that help rapidly ramp up employee efficiency, process optimization, and strategy formulation. This involves building multi-layered solutions that address every need from data ingestion, predictive insights right up to seamless end-user access.
An F100 biopharma wanted to empower its finance function to supervise pan-organizational money flows better with cutting-edge analytics capabilities that:
- Optimized usage of its centralized dashboard
- Streamlined ticket management and issue resolution for the internal support solution
- Aligned accounts payable and fixed assets workflows and analytics to drive strategy.
Solution
MResult MLabs teams collaborated with the client to build analytics solutions that enabled process oversight as well as predictive capability, were completely customizable, and were quickly scalable.
At the F100 biopharma the MResult MLabs team:
- Created a first-of-its-kind solution to track and report user access and activity across web and mobile at a local and global level. The extracted and authenticated information was ported to a cloud-based storage solution, mapped efficiently, and API-based data validation was set up. The end-to-end framework solution could automatically scale
- Developed a proof-of-concept of an integrated and interactive dashboard to monitor ticket information. Key metrics related to usage were identified, tracked, and monitored. The system also tracked the health of the underlying application, including down-time and recurring issues
- Built out a unified data hub designed to ingest and consolidate accounts payable and fixed assets data from various sources, and an analytics layer that included models incorporating business logic and product-specific performance metrics and KPIs.
Impact
The high-end customized analytics solutions helped employees work better, and leaders to optimize processes, save costs, and leverage information for strategy formulation. At the F100 biopharma: